✉news HealthMedicine first seen 8 h ago, last 4 h ago, peak #19
Kodiak Sciences Says Its Eye Drug Matches Regeneron's Medicine
Original: Kodiak Sciences Says Eye Drug on Par with Regeneron's Medicine
Kodiak Sciences announced that its experimental eye drug performs on par with Regeneron's established treatment, according to a Benzinga report. The claim, if supported by trial data, would position the biotech as a credible challenger in the competitive market for retinal disease therapies, where Regeneron's medicine has long been a dominant option.
Why now: Investors and eye-care specialists are reacting to Kodiak Sciences' claim that its drug is as effective as Regeneron's leading therapy.
Rank over time, top of the chart is #1. 4 snapshots from 8 h ago to 4 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/243958